Clinical Trial: A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD)

U.S., July 22 -- ClinicalTrials.gov registry received information related to the study (NCT07716618) titled 'A Phase II Clinical Trial of the Safety and Efficacy of SAL0120 in Patients With Chronic Kidney Disease (CKD)' on July 16.

Brief Summary: This study is a multicenter, randomized, double-blind, placebo-controlled, parallel-design clinical trial designed to investigate the efficacy and safety of different doses of sal0120 tablets in patients with CKD.

Study Start Date: Jan. 17, 2025

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease

Intervention: DRUG: SAL0120 1mg

SAL0120 1mg

DRUG: SAL0120 2mg

SAL0120 2mg

DRUG: SAL0120 4mg

SAL0120 4mg

DRUG: Placebo

placebo

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: She...